INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,581,808 | -17.7% | 107,157 | 0.0% | 3.04% | -15.2% |
| Q2 2023 | $6,785,181 | +5.7% | 107,157 | -9.6% | 3.58% | -8.8% |
| Q1 2023 | $6,422,190 | -22.3% | 118,600 | -24.1% | 3.93% | -29.7% |
| Q4 2022 | $8,268,750 | +7.1% | 156,250 | -5.9% | 5.59% | +12.0% |
| Q3 2022 | $7,724,000 | -34.5% | 165,999 | -19.6% | 4.99% | -28.9% |
| Q2 2022 | $11,792,000 | -19.2% | 206,588 | -13.4% | 7.02% | +9.9% |
| Q1 2022 | $14,594,000 | -22.3% | 238,500 | -33.6% | 6.39% | -16.1% |
| Q4 2021 | $18,790,000 | +33.0% | 359,000 | -5.3% | 7.62% | +22.2% |
| Q3 2021 | $14,129,000 | -7.7% | 379,000 | +1.1% | 6.24% | +15.0% |
| Q2 2021 | $15,308,000 | +6.3% | 375,000 | -11.7% | 5.42% | -13.4% |
| Q1 2021 | $14,403,000 | +6.7% | 424,500 | 0.0% | 6.26% | +12.4% |
| Q4 2020 | $13,499,000 | +23.2% | 424,500 | -0.6% | 5.57% | -0.6% |
| Q3 2020 | $10,957,000 | +0.3% | 427,000 | +0.4% | 5.60% | -8.3% |
| Q2 2020 | $10,923,000 | +64.3% | 425,500 | -1.6% | 6.11% | +40.5% |
| Q1 2020 | $6,648,000 | -58.6% | 432,500 | -7.6% | 4.35% | -57.2% |
| Q4 2019 | $16,060,000 | – | 468,073 | – | 10.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |